The use of intravenous iron in pregnancy: for whom and when? A survey of Australian and New Zealand obstetricians.

ABSTRACT:

Background

Iron deficiency anaemia in pregnancy (IDAP) affects 11-18% of Australian pregnancies and is associated with adverse perinatal outcomes. National prescribing data suggests the use of intravenous iron in pregnancy is increasingly common. This study aimed to: 1) Establish the current patterns of intravenous iron use by Fellows of the Royal Australian and New Zealand College of Obstetricians (FRANZCOG) when treating iron deficiency and IDAP including immediately postpartum and; 2) Assess FRANZCOG opinions regarding potential trial of intravenous iron for first-line treatment of IDAP.

Methods

An online survey of RANZCOG Fellows practicing obstetrics was distributed in September 2018. Results were analysed descriptively and responses compared by clinician demographics u

SUBMITTER: Smith-Wade S 

PROVIDER: S-EPMC7640437 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature